TGFB1 and neoplasm: Indeed, the production of TGF-β by tumor and stromal cells in response to radiotherapy and chemotherapy contributes to treatment resistance [6], and TGF-β inhibition in these cases improves treatment responses, particularly in models of solid carcinomas such as breast cancer [7].